the market?
Covance, Inc.
NYSE: CVD
76.67
0.15
(0.20%)
| Today's Open | $76.09 |
|---|---|
| Previous Close | $76.52 |
| Daily Range | $75.42 - $76.99 |
| 52-Week Range | $44.92 - $78.36 |
| Market Cap | $4.3B |
| P/E Ratio | 39.44 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 196,751 |
| Average Daily Volume | 421,876 |
| Current FY EPS | $3.13 |
How do you think CVD
will perform against the market?
Top CVD Bull/Bear Pitches
EldrehadsPicks (< 20)
Submitted
February 29, 2008
Let’s face it, investing in drug developers isn’t easy. First, there’s the science risk – the chance that the company’s best drug prospect will fail somewhere during the arduous clinical trial and re … More
News & Commentary
Covance Beats on Both Top and Bottom Lines
Just the facts, Fool.Covance: Making Bucks More Quickly
Don't just count the cash, time it.Covance Beats on Both Top and Bottom Lines
Just the facts, Fool.After-Hours Earnings Report for January 24, 2013 : MSFT, T, SBUX, ED, JNPR, MXIM, KLAC, JBHT, RMD,
After-Hours Earnings Report for January 24, 2013 : MSFT, T, SBUX, ED, JNPR, MXIM, KLAC, JBHT, RMD, VRSN, FLEX, CVDWill These Numbers from Covance Be Good Enough for You?
Checking expectationsIs Covance's Cash Flow Just For Show?
All cash flow is not created equal.What Shorts Might Be Watching at Covance
Look here for a clue.Sector
Healthcare
Industry
Healthcare Information Services
Covance, Inc. (CVD) Description
A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries. Website: http://www.covance.com/
CEO Rating by Glassdoor
More details for Covance Jobs
Covance reviews from employees
